Epix to retain Nasdaq listing

AuntMinnie.com staff writers
Feb 8, 2009

MRI contrast developer Epix Pharmaceuticals of Lexington, MA, said that its request for continued listing on the Nasdaq Global Market has been granted.

The ruling by the Nasdaq Listing Qualifications Panel is subject to the condition that Epix file a current report on Form 8-K with the U.S. Securities and Exchange Commission (SEC) by May 11, attesting to its compliance with SEC requirements of maintaining shareholders' equity of at least $10 million or a minimum market value of listed securities of $50 million.

Related Reading

Epix gets FDA OK for Vasovist, December 23, 2008

Epix reduces its workforce, October 23, 2008

Epix to form technology advisory board, August 14, 2008

Epix's Q2 results show boosted revenues, August 7, 2008

Epix secures equity financing, August 5, 2008

Copyright © 2009 AuntMinnie.com

Latest in Clinical News
2024 04 19 7 Year Old Boy With Autoimmune Sclerosing Cholangitis
MR elastography effective for assessing liver stiffness in children
April 19, 2024
FREE WEBINAR: Advanced visualization in 2024: Enhancing radiology care
Sponsored
FREE WEBINAR: Advanced visualization in 2024: Enhancing radiology care
April 17, 2024
Stroke Skull Xray 400
Can ChatGPT ‘data mine’ patient reports for stroke registries?
April 19, 2024
Tspo Thumbnail
PET/MRI reveals sex differences in patients with autism
April 18, 2024
Related Stories
2009 02 06 16 07 25 41 Ajr Figure2
Breast
Radiologists overestimate breast imaging malpractice risk
2009 02 05 10 42 52 878 2009 02 05 Mummy
CT
Philips CT images Egyptian mummy
2009 02 04 12 42 48 637 2009 02 05 Osteo Thumb
MRI
Sodium MRI at 3 tesla detects early signs of osteoarthritis
My BreastAI Suite by GE HealthCare
Sponsor Content
My BreastAI Suite by GE HealthCare
More in Clinical News
MR elastography effective for assessing liver stiffness in children
By Kate Madden Yee
MR elastography is an effective technique for noninvasive monitoring of liver stiffness -- a surrogate for fibrosis -- in children and young adults with autoimmune liver disease, researchers have reported.
April 19, 2024
2024 04 19 7 Year Old Boy With Autoimmune Sclerosing Cholangitis
High breast density tied to impaired recurrence-free cancer survival
By Amerigo Allegretto
Recurrence-free breast cancer survival is less likely in women with high breast density compared with women with low density.
April 19, 2024
Breast Mammography Scanner
Can ChatGPT ‘data mine’ patient reports for stroke registries?
By Will Morton
ChatGPT-4 appears useful for extracting details from reports on thrombectomy procedures in stroke patients, a labor-intensive and error-prone task currently performed by human readers.
April 19, 2024
Stroke Skull Xray 400
PET/MRI reveals sex differences in patients with autism
By Will Morton
PET/MRI shows that young women with autism spectrum disorder have increased brain metabolism associated with translocator protein.
April 18, 2024
Tspo Thumbnail
Radiologist consultation improves patients' LCS attitudes
By Kate Madden Yee
Consulting with a radiologist boosts patients' attitudes toward lung cancer screening (LCS) and their interest in quitting smoking, researchers have reported.
April 18, 2024
Doctor Female Young Desk 400
PET tracer for gliomas under expedited review
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to Telix Pharmaceuticals’ PET radiotracer F-18 floretyrosine (Pixclara) for imaging progressive or recurring gliomas.
April 17, 2024
Gliomas
AI proposed to help radiologists detect child abuse injuries
By Will Morton
A team at Michigan State University has developed an AI model designed to detect rib fractures in children under 3 years old.
April 17, 2024
Test set images with ground truth (teal, red) and model predictions (green, yellow), with true positives (green), false positives (yellow), and false negatives (red). Predictions from the 6x-YOLOv5 ensemble trained on histogram equalized input images with a y = 0.2 avalanche scheme, achieving 0.536 precision, 0.795 recall, and 0.723 F2 score. Image and caption courtesy of Scientific Reports.
Tailored lung cancer screening model helps determine nodule follow-up
By Kate Madden Yee
A personalized lung cancer screening model used with patients with pulmonary nodules identified on low-dose CT helps clinicians determine how to follow up better than rule-based protocols, researchers have found.
April 17, 2024
Lung Cancer
POCUS used widely in lung ultrasound applications
By Amerigo Allegretto
Some of the top domains for users of point-of-care ultrasound (POCUS) incorporate the technology for lung ultrasound applications.
April 17, 2024
Screenshot (1142)
CT-based deep learning identifies patients at further lung cancer risk
By Kate Madden Yee
A CT-based deep learning model can identify individuals with clinical stage IA non-small cell lung cancer (NSCLC) at high risk of further disease, researchers have found.
April 16, 2024
Ai
Deep-learning model determines breast tumor staging
By Amerigo Allegretto
A deep-learning model based on mammographic images can determine tumor staging and sentinel lymph node metastasis in breast cancer patients.
April 16, 2024
Researchers explain the data preparation and structure of a proposed CNN-based deep learning model using mammography features to determine breast tumor staging. The image is available for use under a Creative Commons license: CC BY-NC-ND 4.0 DEED Attribution-NonCommercial-NoDerivs 4.0 International.
FAPI-PET shows promise in patients with lung cancer
By Will Morton
FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans.
April 15, 2024
F-18 FDG and Ga-68 FAPI-46 images of a 51-year-old woman with adenocarcinoma with lepidic growth pattern in right upper lobe. (A) Maximum-intensity-projection PET images. The lesion had F-18 FDG uptake below blood pool level but was strongly Ga-68 FAPI-46-positive. CT-guided biopsy led to pathologic diagnosis of adenocarcinoma, and the patient was treated by stereotactic body radiation therapy because of functional inoperability. Image courtesy of the Journal of Nuclear Medicine.
Page 1 of 3587
Next Page